March 2, 2026

Alkermes plc (ALKS) Stock Analysis: Exploring a 45% Potential Upside in Biopharma

Alkermes plc (NASDAQ: ALKS) stands as a notable player in the biopharmaceutical sector, focusing on addressing unmet medical needs across a spectrum of therapeutic areas. Based in Dublin, Ireland, the..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Understanding the 25.56% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology industry, specializing in RNA-targeted therapeutics and gene therapies aimed at treating rare diseases. With a market capitalization of..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 11.20% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (BTSG) is capturing the attention of investors with a notable 11.20% potential upside, as indicated by its average target price of $46.07. As a key player..

Elanco Animal Health (ELAN) Stock Analysis: Navigating a 8.97% Potential Upside in the Booming Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing for animals. With a market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Research Sector with 10.48% Upside Potential

For investors keen on the healthcare sector, Charles River Laboratories International, Inc. (NYSE: CRL) offers a unique blend of opportunities within the diagnostics and research industry. With a market capitalization..

Axsome Therapeutics (AXSM): Analyst Consensus Highlights 35% Potential Upside for This Biotech Innovator

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a New York-based biopharmaceutical company, continues to capture investor attention with its focus on developing therapies for central nervous system (CNS) disorders. With a market..

TG Therapeutics, Inc. (TGTX) Growth Potential: Navigating a 47.65% Upside in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is making waves with its promising pipeline and substantial market potential. With a market capitalization of $4.78 billion,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Impressive Growth Potential Amidst Innovative Biotechnology Advances

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its robust pipeline of clinical-stage biopharmaceuticals. Headquartered in London, United Kingdom,..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 1.87% Upside with Robust Revenue Growth

Bausch + Lomb Corporation (NYSE: BLCO), a prominent name in the healthcare sector, is making waves in the medical instruments and supplies industry. With its Canadian roots and a market..

Option Care Health, Inc. (OPCH) Investor Outlook: Capitalizing on a 23.51% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the healthcare sector with a focus on medical care facilities, stands out as a formidable player in the home and alternate..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a Pivotal Moment with a 0.28 Forward P/E

Dr. Reddy’s Laboratories Ltd (RDY), a prominent player in the healthcare sector, is a name that resonates with both generic and specialty drug manufacturing. Based in India, this pharmaceutical giant..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 178.79% Potential Upside in Rare Disease Therapeutics

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is gaining attention in the biotechnology sector, with a market capitalization of $2.1 billion and a promising focus on rare disease therapeutics. Headquartered in Redwood..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 10.66% Upside Awaits Investors

Investors searching for a promising opportunity in the healthcare sector might find GE HealthCare Technologies Inc. (GEHC) to be a compelling option. With a market capitalization of $38.41 billion, GEHC..

Novo Nordisk A/S (NVO) Investor Outlook: Unpacking a 36.51% Potential Upside

Novo Nordisk A/S (NVO), a Denmark-based pharmaceutical giant, is a name that resonates with innovation and leadership in the healthcare sector. Operating primarily in the Obesity and Diabetes Care and..

Henry Schein, Inc. (HSIC): Investor Outlook with a 7.5% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC) is a stalwart in the healthcare sector, operating within the medical distribution industry. Founded in 1932 and based in Melville, New York, the company is..

Humana Inc. (HUM) Stock Analysis: Exploring a 17.5% Upside Potential for Investors

Humana Inc. (NYSE: HUM), a powerhouse in the healthcare plans industry, presents an intriguing opportunity for investors, highlighted by a potential upside of 17.5%. As a leading provider of medical..

RadNet, Inc. (RDNT) Stock Analysis: Exploring an Attractive 31.43% Upside Potential in the Healthcare Sector

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, has been capturing investor attention with its robust growth potential and strategic positioning within the diagnostics and research industry...

Exact Sciences Corporation (EXAS) Stock Analysis: Evaluating Growth Prospects Amidst Strong Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Known for its innovative cancer screening and diagnostic test products,..

Tempus AI, Inc. (TEM) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector with its innovative offerings and impressive revenue growth. With a market capitalization of $9.52 billion, Tempus AI..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 59% Potential Upside in the Booming Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its innovative approach to healthcare technology and substantial growth potential. As a leader in the medical devices industry, iRhythm offers..

Search

Funds

March 2, 2026

Search

Funds

March 2, 2026

FTSE 100

Funds